Vancouver, Canada

Ludger M Ickenstein

This inventor holds 1 USPTO granted patent and 1 published patent application, plus 1 CIPO patent and 1 EPO patent. Top assignee: Celator Pharmaceuticals, Inc.. Active years: 2013.

USPTO Granted Patents = 1 

% Patents Active = 100.0



Average Co-Inventor Count = 4.0

ph-index = 1

Forward Citations = 41(Granted Patents)


Company Filing History:


Years Active: 2013

Loading Chart...
Loading Chart...
Loading Chart...
1 patent (USPTO):Explore Patents

Title: Ludger M Ickenstein: Innovator in Lipid Carrier Compositions

Introduction

Ludger M Ickenstein is a notable inventor based in Vancouver, Canada. He has made significant contributions to the field of lipid carrier compositions, particularly in enhancing blood stability. His innovative work has implications for various medical applications, especially in drug delivery systems.

Latest Patents

Ickenstein holds a patent for "Lipid carrier compositions with enhanced blood stability." This patent describes liposomes that contain at least 10 mol % of a negatively charged lipid coupled to a non-zwitterionic moiety, which ensures their stability in the blood. Additionally, liposomes containing at least 1 mol % of such lipids can be safely frozen, providing versatility in their application.

Career Highlights

Ludger M Ickenstein is currently associated with Celator Pharmaceuticals, Inc., where he continues to advance his research and development efforts. His work at the company focuses on innovative solutions in the pharmaceutical industry, particularly in improving drug delivery mechanisms.

Collaborations

Ickenstein has collaborated with notable colleagues such as Paul Tardi and Murray Webb. These partnerships have fostered a collaborative environment that enhances the research and development of lipid-based therapies.

Conclusion

Ludger M Ickenstein's contributions to lipid carrier compositions highlight his role as an innovator in the pharmaceutical field. His patent on enhancing blood stability in liposomes showcases the potential for improved drug delivery systems. His ongoing work at Celator Pharmaceuticals, Inc. continues to pave the way for advancements in medical technology.

Profile summary based on public USPTO records.
Please report any incorrect information to [email protected]
Loading…